TOTAL HEALTHCARE LEADER, 동구바이오제약 진단·치료·예방·관리를 위해 토털 솔루션을 제공합니다.
Aesthetic/plastic surgery based on stem cell kit + success experiences of PRP marketing: In 2014, this was the first year of Bio R&D and we expand the area of various fields in a pain treatment starting from the aesthetic/ plastic fields by the release of stem cell kit for the first time in domestic based on the patent technique at the first half year. We are on the process of going forward to international markets as well as domestic markets. anti-snoring treatment + entry of otolaryngology : we will be on the process of clinical and permission in 2014 about No-Snore Tray, a oral device for the obstructive sleep apnea syndrome treatment without the surgery or adjusting device.
R&D strengthening ability.
We have strengthen R&D by establishing the central research institute and have improved the quality of products through the ‘Connect & Develop’ modelMajor branded medical products that are produced by excellent original and generic R&D competitiveness of Dongkoo Bio&Pharma. Co., Ltd. are "Cenilton" that is the prostate treatment that is partnership with Cerbios-pharma, Swiss, "Ventrux", active probiotic intestinal treatment, and " Dentheth ointment", gum diease treatment, Lion Pharmaceutical company, Japan.
Diversification of business area. DongKoo Bio&Pharma. Co., Ltd. is improving sales results of each departments; skin/urology as well as other medical fields, household items, health functional foods, 1)CMO business and etc. We do not settle down the treatment markets and go forward to prevention/control markets. Also, We are approaching the market with the concept of 'Total Solution' through the entry of bio industry with the buyout of novacelltechnology containing protein analysis source technique, expansion of medical device industry, medical products, health functional foods, and CMO business1) CMO (Contract Manufacturing Organization)
Enter into the global market. In present, we export our brilliant products to various countries including Vietnam, New Zealand, Thailand, Hong Kong and Singapore. We are pushing ahead ourselves in order to meet strict import regulations for medical products of advanced countries such as the European Union, Japan, China and the U.S. in the future. We are specialized in soft gelatin capsule products. We are getting an excellent evaluation from international buyers as a GMP manufacturer. Also, we secure the cost-competitiveness by building R&D base/production, and reducing API(Active Pharmaceutical Ingredient) costs.
Science-related marketing methods. We will be a company which has a systematic marketing power both locally and abroad. The driving force will be based on manufacturing competitiveness and high-value bio-products through the strong ability of sales and in-depth relation-marketing activities on the field, scholarship and scientific marketing.
We, DongKoo Bio&Pharma Co., Ltd. pursuit the development of company and human health combining constant challenge with the cutting edge technologies.We aim to increase market dominating power and maximize our company value training manpower developing pacesetting products